Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
new option listings and one option delisting on June 30th » 08:30
06/30/21
06/30
08:30
06/30/21
08:30
ARKO

Arko Corp.

$9.05 /

-0.25 (-2.69%)

, AXLA

Axcella Health

$3.99 /

-0.04 (-0.99%)

, BAB

British Airways

$33.06 /

-0.005 (-0.02%)

, BMTX

BM Technologies

$12.69 /

+0.14 (+1.12%)

, BTRS

Billtrust

$13.00 /

-0.7 (-5.11%)

, CLXT

Calyxt

$3.99 /

-0.08 (-1.97%)

, COGT

Cogent Biosciences

$8.03 /

+0.0598 (+0.75%)

, CTXR

Citius Pharmaceuticals

$3.51 /

-0.2 (-5.40%)

, DCRC

Decarbonization Plus Acquisition III

$10.46 /

-0.09 (-0.85%)

, ELYS

Elys Game Technology

$4.18 /

-0.17 (-3.91%)

, FBRX

Forte Biosciences

$32.67 /

-1.71 (-4.97%)

, FVE

Five Star Senior Living

$5.70 /

-0.19 (-3.23%)

, III

Information Services

$5.79 /

-0.05 (-0.86%)

, ISUN

iSun

$11.79 /

-0.63 (-5.07%)

, NEGG

Newegg Commerce

$10.94 /

+0.72 (+7.05%)

, NOVN

Novan

$10.20 /

-0.3 (-2.86%)

, NSPR

InspireMD

$5.09 /

-0.23 (-4.32%)

, OCUP

Ocuphire Pharma

$4.74 /

-0.11 (-2.27%)

, PANL

Pangaea Logistics

$4.96 /

+0.15 (+3.12%)

, RADI

Radius Global Infrastructure

$14.40 /

-0.21 (-1.44%)

, SQZ

SQZ Biotechnologies

$13.92 /

-0.3 (-2.11%)

, TBLA

Taboola

/

+

, TGLS

Tecnoglass

$20.60 /

-0.2325 (-1.12%)

, TLIS

Talis Biomedical

$10.65 /

-0.89 (-7.71%)

, VMD

Viemed Healthcare

$7.47 /

+ (+0.00%)

, VVOS

Vivos Therapeutics

$4.87 /

-0.12 (-2.40%)

, YQ

17 Education & Technology

$3.47 /

-0.17 (-4.67%)

, IACA

ION Acquisition Corp 1

$10.51 /

+0.33 (+3.24%)

New option listings for…

New option listings for June 30th include iShares Agency Bond (AGZ), ARKO Corporation (ARKO), Axcella Health Inc (AXLA), PowerShares Build America Bond Portfolio (BAB), BM Technologies Inc (BMTX), BTRS Holdings Inc (BTRS), Calyxt Inc (CLXT), Cogent Biosciences Inc (COGT), Citius Pharmaceuticals Inc (CTXR), Decarbonization Plus Acquisition Corporation III (Class A Stock) (DCRC), Elys Game Technology Corporation (ELYS), Forte Biosciences (FBRX), Franklin FTSE Brazil ETF (FLBR), Five Star Quality (FVE), IQ S&P High Yield Low Volatility Bond ETF (HYLV), Information Services (III), iSun Inc (ISUN), KraneShares MSCI China Clean Technology Index ETF (KGRN), Newegg Commerce Inc (NEGG), Novan (NOVN), InspireMD (NSPR), Ocuphire Pharma Inc (OCUP), Pangaea Logistics (PANL), WisdomTree CBOE S&P 500 PutWrite Strategy Fund (PUTW), Radius Global Infrastructure Inc (Class A Stock) (RADI), Schwab 1 to 5 Year Corporate Bond ETF (SCHJ), SQZ Biotechnologies Company (SQZ), Taboola com Ltd (TBLA), Tecnoglass (TGLS), SPDR Barclays 1 to 10 Year TIPS (TIPX), Talis Biomedical Corporation (TLIS), VieMed Healthcare Inc (VMD), Vivos Therapeutics Inc (VVOS), Invesco S&P SmallCap Value with Momentum ETF (XSVM), 17 Education and Technology Group Inc (ADS) (YQ), and YieldShares High Income (YYY). Option delistings effective June 30th include ION Acquisition Corp 1 Ltd (Class A Stock) (IACA).

ShowHide Related Items >><<
VVOS Vivos Therapeutics
$4.87 /

-0.12 (-2.40%)

VMD Viemed Healthcare
$7.47 /

+ (+0.00%)

TLIS Talis Biomedical
$10.65 /

-0.89 (-7.71%)

TGLS Tecnoglass
$20.60 /

-0.2325 (-1.12%)

TBLA Taboola
/

+

SQZ SQZ Biotechnologies
$13.92 /

-0.3 (-2.11%)

RADI Radius Global Infrastructure
$14.40 /

-0.21 (-1.44%)

PANL Pangaea Logistics
$4.96 /

+0.15 (+3.12%)

OCUP Ocuphire Pharma
$4.74 /

-0.11 (-2.27%)

NSPR InspireMD
$5.09 /

-0.23 (-4.32%)

NOVN Novan
$10.20 /

-0.3 (-2.86%)

NEGG Newegg Commerce
$10.94 /

+0.72 (+7.05%)

ISUN iSun
$11.79 /

-0.63 (-5.07%)

III Information Services
$5.79 /

-0.05 (-0.86%)

IACA ION Acquisition Corp 1
$10.51 /

+0.33 (+3.24%)

FVE Five Star Senior Living
$5.70 /

-0.19 (-3.23%)

FBRX Forte Biosciences
$32.67 /

-1.71 (-4.97%)

ELYS Elys Game Technology
$4.18 /

-0.17 (-3.91%)

DCRC Decarbonization Plus Acquisition III
$10.46 /

-0.09 (-0.85%)

CTXR Citius Pharmaceuticals
$3.51 /

-0.2 (-5.40%)

COGT Cogent Biosciences
$8.03 /

+0.0598 (+0.75%)

CLXT Calyxt
$3.99 /

-0.08 (-1.97%)

BTRS Billtrust
$13.00 /

-0.7 (-5.11%)

AXLA Axcella Health
$3.99 /

-0.04 (-0.99%)

ARKO Arko Corp.
$9.05 /

-0.25 (-2.69%)

ARKO Arko Corp.
$9.05 /

-0.25 (-2.69%)

03/19/21 Stifel
Arko Corp. initiated with a Buy at Stifel
02/05/21
Fly Intel: Top five analyst initiations
02/05/21 Raymond James
Arko Corp. initiated with a Strong Buy at Raymond James
02/04/21 Raymond James
Arko Corp. initiated with a Strong Buy at Raymond James
AXLA Axcella Health
$3.99 /

-0.04 (-0.99%)

06/03/21 Chardan
Axcella Health price target raised to $16 from $10 at Chardan
04/13/21 Piper Sandler
Piper says IND clearance sets up Axcella Health for potential NASH 'home run'
03/22/21 Wedbush
Axcella Health price target lowered to $11 from $19 at Wedbush
03/18/21 Chardan
Axcella Health moving forward with two lead programs, says Chardan
BAB British Airways
$33.06 /

-0.005 (-0.02%)

BMTX BM Technologies
$12.69 /

+0.14 (+1.12%)

06/03/21 Maxim
BM Technologies initiated with a Buy at Maxim
BTRS Billtrust
$13.00 /

-0.7 (-5.11%)

04/30/21 JPMorgan
Billtrust initiated with a Neutral at JPMorgan
04/22/21 Cowen
Billtrust initiated with an Outperform at Cowen
03/18/21 KeyBanc
Billtrust initiated with an Overweight at KeyBanc
03/10/21 Needham
Billtrust initiated with a Buy at Needham
CLXT Calyxt
$3.99 /

-0.08 (-1.97%)

05/10/21 Canaccord
Calyxt price target lowered to $7 from $16 at Canaccord
02/16/21 Canaccord
Calyxt price target raised to $16 from $8 at Canaccord
12/15/20 Berenberg
Calyxt initiated with a Buy at Berenberg
12/10/20
Fly Intel: Top five analyst initiations
COGT Cogent Biosciences
$8.03 /

+0.0598 (+0.75%)

06/09/21 Jefferies
Cogent Biosciences assumed with a Buy at Jefferies
05/12/21 Piper Sandler
Piper remain buyers of Cogent Biosciences after 'relatively quiet' Q1 report
12/23/20 Piper Sandler
Cogent Biosciences initiated with an Overweight at Piper Sandler
12/17/20 SVB Leerink
Cogent Biosciences initiated with an Outperform at SVB Leerink
CTXR Citius Pharmaceuticals
$3.51 /

-0.2 (-5.40%)

DCRC Decarbonization Plus Acquisition III
$10.46 /

-0.09 (-0.85%)

ELYS Elys Game Technology
$4.18 /

-0.17 (-3.91%)

03/10/21
Fly Intel: Top five analyst initiations
03/10/21 H.C. Wainwright
Elys Game Technology initiated with a Buy at H.C. Wainwright
FBRX Forte Biosciences
$32.67 /

-1.71 (-4.97%)

05/14/21
Fly Intel: Top five analyst initiations
05/14/21 B. Riley
B. Riley starts Forte Biosciences with Buy rating, $73 price target
05/13/21 B. Riley
Forte Biosciences initiated with a Buy at B. Riley
03/26/21 Citi
Forte Biosciences initiated with a Buy at Citi
FVE Five Star Senior Living
$5.70 /

-0.19 (-3.23%)

05/10/21 B. Riley
Five Star Senior Living price target raised to $8 from $7.50 at B. Riley
04/12/21 B. Riley
Five Star Senior Living price target lowered to $7.50 from $8.50 at B. Riley
12/10/20 Wells Fargo
Diversified Healthcare Trust downgraded to Underweight from Equal Weight at Wells Fargo
08/25/20
Fly Intel: Top five analyst initiations
III Information Services
$5.79 /

-0.05 (-0.86%)

05/12/21 Barrington
Information Services upgraded to Outperform from Market Perform at Barrington
05/12/21 Noble Capital
Information Services price target raised to $7 from $5 at Noble Capital
ISUN iSun
$11.79 /

-0.63 (-5.07%)

06/02/21 Alliance Global Partners
iSun price target lowered to $21.40 from $24 at Alliance Global Partners
NEGG Newegg Commerce
$10.94 /

+0.72 (+7.05%)

NOVN Novan
$10.20 /

-0.3 (-2.86%)

06/17/21 Needham
Verrica Pharmaceuticals's Ycanth offers superior efficacy to Novan, says Needham
06/14/21 H.C. Wainwright
Novan price target raised to $28 from $20 at H.C. Wainwright
06/11/21 Roth Capital
Novan price target raised to $40 from $26 at Roth Capital
04/22/21
Fly Intel: Top five analyst initiations
NSPR InspireMD
$5.09 /

-0.23 (-4.32%)

10/16/20 Alliance Global Partners
InspireMD initiated with a Buy at Alliance Global Partners
OCUP Ocuphire Pharma
$4.74 /

-0.11 (-2.27%)

06/01/21 JonesTrading
Jones Trading bullish on Ocuphire, sees 'under the radar' revenue opportunity
04/05/21 Alliance Global Partners
Ocuphire Pharma initiated with a Buy at Alliance Global Partners
03/29/21 JonesTrading
Ocuphire Pharma initiated with a Buy at JonesTrading
03/15/21 Canaccord
Ocuphire shares should move 'meaningfully higher' on data, says Canaccord
PANL Pangaea Logistics
$4.96 /

+0.15 (+3.12%)

RADI Radius Global Infrastructure
$14.40 /

-0.21 (-1.44%)

04/22/21 Raymond James
Raymond James starts Radius Global Infrastructure at Outperform on pricing power
04/22/21 Raymond James
Radius Global Infrastructure initiated with an Outperform at Raymond James
04/12/21 Jefferies
Radius Global Infrastructure initiated with a Buy at Jefferies
12/29/20 LightShed Partners
Radius Global Infrastructure initiated with a Buy at LightShed Partners
SQZ SQZ Biotechnologies
$13.92 /

-0.3 (-2.11%)

03/30/21 Brookline
SQZ Biotechnologies initiated with a Buy at Brookline
01/07/21 Evercore ISI
SQZ Biotechnologies initiated with an Outperform at Evercore ISI
11/24/20 Stifel
SQZ Biotechnologies initiated with a Buy at Stifel
11/24/20 BofA
SQZ Biotechnologies initiated with a Buy at BofA
TBLA Taboola
/

+

TGLS Tecnoglass
$20.60 /

-0.2325 (-1.12%)

06/02/21
Fly Intel: Top five analyst downgrades
06/02/21 B. Riley
Tecnoglass downgraded to Neutral after 240% rally at B. Riley
06/02/21 B. Riley
Tecnoglass downgraded to Neutral from Buy at B. Riley
05/10/21 B. Riley
Tecnoglass price target raised to $17 from $14 at B. Riley
TLIS Talis Biomedical
$10.65 /

-0.89 (-7.71%)

05/12/21 Piper Sandler
Talis Biomedical price target lowered to $13 from $17 at Piper Sandler
03/09/21 JPMorgan
Talis Biomedical initiated with an Overweight at JPMorgan
03/09/21 BofA
BofA starts Talis Biomedical at Neutral with $14 price target
03/09/21 BTIG
Talis Biomedical initiated with a Buy at BTIG
VMD Viemed Healthcare
$7.47 /

+ (+0.00%)

03/05/21 RBC Capital
Viemed Healthcare initiated with an Outperform at RBC Capital
VVOS Vivos Therapeutics
$4.87 /

-0.12 (-2.40%)

01/11/21 Craig-Hallum
Craig-Hallum bullish on Vivos Therapeutics, initiates with a Buy
01/11/21 Craig-Hallum
Vivos Therapeutics initiated with a Buy at Craig-Hallum
01/05/21 Roth Capital
Vivos Therapeutics initiated with a Buy at Roth Capital
YQ 17 Education & Technology
$3.47 /

-0.17 (-4.67%)

06/16/21 Morgan Stanley
Morgan Stanley cuts 17 Education & Technology to Underweight on K9-related risk
06/16/21 Morgan Stanley
TAL Education cut to Underweight on K9-related business risk at Morgan Stanley
06/16/21 Morgan Stanley
New Oriental Education downgraded on K9-related business risk at Morgan Stanley
06/16/21 Morgan Stanley
17 Education downgraded to Underweight from Overweight at Morgan Stanley
IACA ION Acquisition Corp 1
$10.51 /

+0.33 (+3.24%)

VMD Viemed Healthcare
$7.47 /

+ (+0.00%)

TGLS Tecnoglass
$20.60 /

-0.2325 (-1.12%)

SQZ SQZ Biotechnologies
$13.92 /

-0.3 (-2.11%)

RADI Radius Global Infrastructure
$14.40 /

-0.21 (-1.44%)

PANL Pangaea Logistics
$4.96 /

+0.15 (+3.12%)

OCUP Ocuphire Pharma
$4.74 /

-0.11 (-2.27%)

III Information Services
$5.79 /

-0.05 (-0.86%)

FVE Five Star Senior Living
$5.70 /

-0.19 (-3.23%)

FBRX Forte Biosciences
$32.67 /

-1.71 (-4.97%)

ELYS Elys Game Technology
$4.18 /

-0.17 (-3.91%)

CTXR Citius Pharmaceuticals
$3.51 /

-0.2 (-5.40%)

COGT Cogent Biosciences
$8.03 /

+0.0598 (+0.75%)

BTRS Billtrust
$13.00 /

-0.7 (-5.11%)

AXLA Axcella Health
$3.99 /

-0.04 (-0.99%)

ARKO Arko Corp.
$9.05 /

-0.25 (-2.69%)

  • 01
    Jul
  • 17
    Jun
  • 12
    Feb
  • 12
    Feb
  • 04
    Feb
  • 11
    Dec
  • 02
    Dec
  • 04
    Dec
  • 29
    Oct
  • 30
    Oct
DCRC Decarbonization Plus Acquisition III
$10.46 /

-0.09 (-0.85%)

TLIS Talis Biomedical
$10.65 /

-0.89 (-7.71%)

NOVN Novan
$10.20 /

-0.3 (-2.86%)

IACA ION Acquisition Corp 1
$10.51 /

+0.33 (+3.24%)

DCRC Decarbonization Plus Acquisition III
$10.46 /

-0.09 (-0.85%)

BTRS Billtrust
$13.00 /

-0.7 (-5.11%)

IACA ION Acquisition Corp 1
$10.51 /

+0.33 (+3.24%)

Hot Stocks
SQZ Biotechnologies' Cell Squeeze technology shows neuron generation capacity » 06:51
06/23/21
06/23
06:51
06/23/21
06:51
SQZ

SQZ Biotechnologies

$12.91 /

-0.655 (-4.83%)

SQZ Biotechnologies…

SQZ Biotechnologies presented preclinical regenerative medicine data showing that the company's Cell Squeeze technology can be used to generate neurons from induced human pluripotent stem cells through the single delivery of an mRNA encoding fate-specifying transcription factor. The new findings build upon recent clinical and pre-clinical research presentations. The regenerative medicine research was presented at the 2021 International Society for Stem Cell Research virtual annual meeting. Findings from cell reprogramming research include: rapid induction of neuronal differentiation; potent target gene expression; multiplexed mRNA capability; maintaining cell health. Together these data show potential of the Cell Squeeze technology to reprogram cells for regenerative medicine applications.

ShowHide Related Items >><<
SQZ SQZ Biotechnologies
$12.91 /

-0.655 (-4.83%)

SQZ SQZ Biotechnologies
$12.91 /

-0.655 (-4.83%)

03/30/21 Brookline
SQZ Biotechnologies initiated with a Buy at Brookline
01/07/21 Evercore ISI
SQZ Biotechnologies initiated with an Outperform at Evercore ISI
11/24/20 Stifel
SQZ Biotechnologies initiated with a Buy at Stifel
11/24/20 BofA
SQZ Biotechnologies initiated with a Buy at BofA
SQZ SQZ Biotechnologies
$12.91 /

-0.655 (-4.83%)

  • 12
    Feb
  • 30
    Oct
Over a month ago
Conference/Events
SQZ Biotechnologies participates in a conference call with Truist » 12:25
06/08/21
06/08
12:25
06/08/21
12:25
SQZ

SQZ Biotechnologies

$13.15 /

-0.065 (-0.49%)

Conference call with…

Conference call with management to discuss data as presented at the ASCO Virtual Meeting will be held on June 8 at 1 pm hosted by Truist.

ShowHide Related Items >><<
SQZ SQZ Biotechnologies
$13.15 /

-0.065 (-0.49%)

SQZ SQZ Biotechnologies
$13.15 /

-0.065 (-0.49%)

03/30/21 Brookline
SQZ Biotechnologies initiated with a Buy at Brookline
01/07/21 Evercore ISI
SQZ Biotechnologies initiated with an Outperform at Evercore ISI
11/24/20 Stifel
SQZ Biotechnologies initiated with a Buy at Stifel
11/24/20 BofA
SQZ Biotechnologies initiated with a Buy at BofA
SQZ SQZ Biotechnologies
$13.15 /

-0.065 (-0.49%)

  • 12
    Feb
  • 30
    Oct
Conference/Events
SQZ Biotechnologies participates in a conference call with Truist » 04:55
06/08/21
06/08
04:55
06/08/21
04:55
SQZ

SQZ Biotechnologies

$13.15 /

-0.41 (-3.02%)

Conference call with…

Conference call with management to discuss data as presented at the ASCO Virtual Meeting will be held on June 8 at 1 pm hosted by Truist.

ShowHide Related Items >><<
SQZ SQZ Biotechnologies
$13.15 /

-0.41 (-3.02%)

SQZ SQZ Biotechnologies
$13.15 /

-0.41 (-3.02%)

03/30/21 Brookline
SQZ Biotechnologies initiated with a Buy at Brookline
01/07/21 Evercore ISI
SQZ Biotechnologies initiated with an Outperform at Evercore ISI
11/24/20 Stifel
SQZ Biotechnologies initiated with a Buy at Stifel
11/24/20 BofA
SQZ Biotechnologies initiated with a Buy at BofA
SQZ SQZ Biotechnologies
$13.15 /

-0.41 (-3.02%)

  • 12
    Feb
  • 30
    Oct
Conference/Events
SQZ Biotechnologies participates in a conference call with Truist » 12:57
06/04/21
06/04
12:57
06/04/21
12:57
SQZ

SQZ Biotechnologies

$13.56 /

+0.01 (+0.07%)

Conference call with…

Conference call with management to discuss data as presented at the ASCO Virtual Meeting will be held on June 8 at 1 pm hosted by Truist.

ShowHide Related Items >><<
SQZ SQZ Biotechnologies
$13.56 /

+0.01 (+0.07%)

SQZ SQZ Biotechnologies
$13.56 /

+0.01 (+0.07%)

03/30/21 Brookline
SQZ Biotechnologies initiated with a Buy at Brookline
01/07/21 Evercore ISI
SQZ Biotechnologies initiated with an Outperform at Evercore ISI
11/24/20 Stifel
SQZ Biotechnologies initiated with a Buy at Stifel
11/24/20 BofA
SQZ Biotechnologies initiated with a Buy at BofA
SQZ SQZ Biotechnologies
$13.56 /

+0.01 (+0.07%)

  • 12
    Feb
  • 30
    Oct
Hot Stocks
SQZ Biotechnologies presents initial results from SQZ-PBMC-HPV trial » 08:03
06/04/21
06/04
08:03
06/04/21
08:03
SQZ

SQZ Biotechnologies

$13.55 /

-0.34 (-2.45%)

SQZ Biotechnologies…

SQZ Biotechnologies presented initial results from its ongoing Phase 1 clinical trial of SQZ-PBMC-HPV demonstrating that the investigational cell therapy is safe and well-tolerated and can stimulate immune responses in certain patients with advanced or metastatic Human Papillomavirus positive, or HPV16+, tumors. The trial also showed that the company's clinical stage manufacturing process of its autologous cell therapy is fast and reliable. The monotherapy stage trial data of the company's first Antigen Presenting Cell, or APC, platform candidate was presented at the 2021 American Society of Clinical Oncology (ASCO) annual meeting; poster presentation 2536. A primary outcome measure in the monotherapy dose escalation phase of the trial is safety and tolerability. Findings from the trial show that SQZ-PBMC-HPV was safe and well-tolerated at all tested dose levels with patients receiving 2 to 10 doses. No dose-limiting toxicities were observed. There were no grade 3 or higher treatment related serious adverse events, or SAEs. In one patient, a grade 2 cytokine release syndrome and immune-related reaction was observed. A related grade 3 adverse event (AE, anemia) was observed in another patient. Manufacturing feasibility is a secondary outcome measure in the monotherapy phase of the trial. All patient batches were produced under current good manufacturing practice regulations, met specifications, and yielded multiple cryopreserved doses in less than 24 hours. The findings show that doses of SQZ-PBMC-HPV were released and available for administration approximately one week from the time a patient's cells were drawn. Antigen presentation was confirmed in all patient batches independent of individual patient medical history or prognostic score.

ShowHide Related Items >><<
SQZ SQZ Biotechnologies
$13.55 /

-0.34 (-2.45%)

SQZ SQZ Biotechnologies
$13.55 /

-0.34 (-2.45%)

03/30/21 Brookline
SQZ Biotechnologies initiated with a Buy at Brookline
01/07/21 Evercore ISI
SQZ Biotechnologies initiated with an Outperform at Evercore ISI
11/24/20 Stifel
SQZ Biotechnologies initiated with a Buy at Stifel
11/24/20 BofA
SQZ Biotechnologies initiated with a Buy at BofA
SQZ SQZ Biotechnologies
$13.55 /

-0.34 (-2.45%)

  • 12
    Feb
  • 30
    Oct
Earnings
SQZ Biotechnologies reports Q1 EPS (59c), consensus (69c) » 16:46
05/11/21
05/11
16:46
05/11/21
16:46
SQZ

SQZ Biotechnologies

$11.39 /

-0.19 (-1.64%)

REports Q1 revenue $5.5M,…

REports Q1 revenue $5.5M, consensus $4.46M. "We continue to execute across our broad and differentiated cell therapy pipeline and are excited by the potential patient impact of these programs to treat cancer, autoimmune, and infectious diseases," said Armon Sharei, Ph.D., Chief Executive Officer at SQZ Biotechnologies. "We have made progress this quarter, including continued advancement of our SQZ APC Phase 1 trial for patients with advanced or metastatic HPV+ tumors; IND clearance of our SQZ AAC program using engineered red blood cells; and presentation of preclinical data from our SQZ TACs in Type 1 diabetes models. We look forward to future milestones as we continue to advance our platforms."

ShowHide Related Items >><<
SQZ SQZ Biotechnologies
$11.39 /

-0.19 (-1.64%)

SQZ SQZ Biotechnologies
$11.39 /

-0.19 (-1.64%)

03/30/21 Brookline
SQZ Biotechnologies initiated with a Buy at Brookline
01/07/21 Evercore ISI
SQZ Biotechnologies initiated with an Outperform at Evercore ISI
11/24/20 Stifel
SQZ Biotechnologies initiated with a Buy at Stifel
11/24/20 BofA
SQZ Biotechnologies initiated with a Buy at BofA
  • 12
    Feb
  • 30
    Oct
Over a quarter ago
Conference/Events
SQZ Biotechnologies management to meet virtually with BTIG » 04:55
04/22/21
04/22
04:55
04/22/21
04:55
SQZ

SQZ Biotechnologies

$12.55 /

+0.305 (+2.49%)

Virtual Meeting to be…

Virtual Meeting to be held on April 22 hosted by BTIG.

ShowHide Related Items >><<
SQZ SQZ Biotechnologies
$12.55 /

+0.305 (+2.49%)

SQZ SQZ Biotechnologies
$12.55 /

+0.305 (+2.49%)

03/30/21 Brookline
SQZ Biotechnologies initiated with a Buy at Brookline
01/07/21 Evercore ISI
SQZ Biotechnologies initiated with an Outperform at Evercore ISI
11/24/20 Stifel
SQZ Biotechnologies initiated with a Buy at Stifel
11/24/20 BofA
SQZ Biotechnologies initiated with a Buy at BofA
  • 12
    Feb
  • 30
    Oct
SQZ SQZ Biotechnologies
$12.55 /

+0.305 (+2.49%)

Conference/Events
SQZ Biotechnologies management to meet virtually with BTIG » 12:49
04/20/21
04/20
12:49
04/20/21
12:49
SQZ

SQZ Biotechnologies

$12.32 /

-0.185 (-1.48%)

Virtual Meeting to be…

Virtual Meeting to be held on April 22 hosted by BTIG.

ShowHide Related Items >><<
SQZ SQZ Biotechnologies
$12.32 /

-0.185 (-1.48%)

SQZ SQZ Biotechnologies
$12.32 /

-0.185 (-1.48%)

03/30/21 Brookline
SQZ Biotechnologies initiated with a Buy at Brookline
01/07/21 Evercore ISI
SQZ Biotechnologies initiated with an Outperform at Evercore ISI
11/24/20 Stifel
SQZ Biotechnologies initiated with a Buy at Stifel
11/24/20 BofA
SQZ Biotechnologies initiated with a Buy at BofA
  • 12
    Feb
  • 30
    Oct
SQZ SQZ Biotechnologies
$12.32 /

-0.185 (-1.48%)

Conference/Events
Canaccord to hold a virtual conference » 09:39
04/15/21
04/15
09:39
04/15/21
09:39
ONCY

Oncolytics

$3.06 /

-0.08 (-2.55%)

, SESN

Sesen Bio

$2.35 /

+0.015 (+0.64%)

, OLMA

Olema Oncology

$35.84 /

+3.56 (+11.03%)

, SQZ

SQZ Biotechnologies

$13.06 /

-0.12 (-0.91%)

, APTO

Aptose Biosciences

$5.20 /

+0.09 (+1.76%)

, BCEL

Atreca

$12.42 /

+0.83 (+7.16%)

, BNTX

BioNTech

$132.52 /

+3.11 (+2.40%)

Horizons in Oncology…

Horizons in Oncology Virtual Conference to be held on April 15.

ShowHide Related Items >><<
SQZ SQZ Biotechnologies
$13.06 /

-0.12 (-0.91%)

SESN Sesen Bio
$2.35 /

+0.015 (+0.64%)

ONCY Oncolytics
$3.06 /

-0.08 (-2.55%)

OLMA Olema Oncology
$35.84 /

+3.56 (+11.03%)

BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

APTO Aptose Biosciences
$5.20 /

+0.09 (+1.76%)

ONCY Oncolytics
$3.06 /

-0.08 (-2.55%)

02/17/21 H.C. Wainwright
Oncolytics initiated with a Buy at H.C. Wainwright
05/11/20 RBC Capital
Oncolytics price target lowered to C$6 from C$9 at RBC Capital
SESN Sesen Bio
$2.35 /

+0.015 (+0.64%)

02/17/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Jefferies
Jefferies doubles target on Sesen Bio to $6 on 'optimal scenario'
01/25/21 Canaccord
Sesen Bio a must-own small cap for 2021, says Canaccord
OLMA Olema Oncology
$35.84 /

+3.56 (+11.03%)

12/14/20 JPMorgan
Olema Oncology initiated with an Overweight at JPMorgan
12/14/20 Jefferies
Olema Pharmaceuticals initiated with a Buy at Jefferies
12/14/20 Canaccord
Olema Pharmaceuticals initiated with a Buy at Canaccord
12/14/20 Cowen
Olema Pharmaceuticals initiated with an Outperform at Cowen
SQZ SQZ Biotechnologies
$13.06 /

-0.12 (-0.91%)

03/30/21 Brookline
SQZ Biotechnologies initiated with a Buy at Brookline
01/07/21 Evercore ISI
SQZ Biotechnologies initiated with an Outperform at Evercore ISI
11/24/20 Stifel
SQZ Biotechnologies initiated with a Buy at Stifel
11/24/20 BofA
SQZ Biotechnologies initiated with a Buy at BofA
APTO Aptose Biosciences
$5.20 /

+0.09 (+1.76%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
BCEL Atreca
$12.42 /

+0.83 (+7.16%)

02/08/21 Jefferies
Atreca initiated with a Buy at Jefferies
08/12/20 Stifel
Volatility in Atreca shares creates 'interesting' opportunity, says Stifel
07/08/20 Piper Sandler
Xencor, Atreca deal offers synergies for XmAb design, says Piper Sandler
07/01/20 Canaccord
Atreca price target raised to $33 from $23 at Canaccord
BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
SESN Sesen Bio
$2.35 /

+0.015 (+0.64%)

ONCY Oncolytics
$3.06 /

-0.08 (-2.55%)

OLMA Olema Oncology
$35.84 /

+3.56 (+11.03%)

BCEL Atreca
$12.42 /

+0.83 (+7.16%)

APTO Aptose Biosciences
$5.20 /

+0.09 (+1.76%)

  • 12
    Feb
  • 19
    Nov
  • 30
    Oct
  • 23
    Jul
  • 16
    Jul
  • 16
    Jul
BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

SQZ SQZ Biotechnologies
$13.06 /

-0.12 (-0.91%)

SESN Sesen Bio
$2.35 /

+0.015 (+0.64%)

OLMA Olema Oncology
$35.84 /

+3.56 (+11.03%)

BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

APTO Aptose Biosciences
$5.20 /

+0.09 (+1.76%)

OLMA Olema Oncology
$35.84 /

+3.56 (+11.03%)

BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.